Publications

Publications of the Eichmüller group (since 2010)

Requesting PDFs

All reprints are available as PDF for personal use on request

Most recent publications

2016

  • Weber CEM et al. (2016) miR-339-3p is a tumor suppressor in melanoma. Cancer Res 76: 3562-3571. Link to full text.
  • Werner S et al. (2016) Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Scientific Reports 6: 25467. Link to full text.
  • Kordaß T et al. (2016) SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Med Genomics 9: 10. Link to full text.
  • Chen H et al. (2016) Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget 7: 16420-32. Link to full text.

2015

  • Gardyan A*, Osen W* et al. (2015) Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice. Int J Cancer 136: 2588-97.
  • Zörnig I et al. (2015) Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 136: 138-51.
  • Pfirschke C et al. (2015) T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response. Cancer Immunol Immunother 64: 1369-81.
  • Lei J et al. (2015) Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy. Plos One 10: e0138458.
  • Hao S et al. (2015) miR-137 inhibits proliferation of melanoma cells by targeting PAK2. Exp Dermatol 24: 947-52.
  • Amann PM et al. (2015) LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid anti-tumor efficacy in the murine melanoma B16F10 cell line. Skin Pharmacol Physiol 28: 205-12.

2014

  • Schumacher T et al. (2014) A vaccine targeting mutant IDH1 induces antitumor immunity. Nature 512: 324-7.
  • Schacht T et al. (2014) Estimating the activity of transcription factors by the effect on their target genes. Bioinformatics 30: i401-i7.
  • Luo C et al. (2014) The role of microRNAs in melanoma. Eur J Cell Biol 93: 11-22.
  • Amann PM et al. (2014) Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells. Exp Dermatol 23: 832-7.

2013

  • Simon-Keller K et al. (2013) Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholin receptor-redirected T cells. Am J Pathol 182: 2121-31.
  • Luo C et al. (2013) miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 133: 768-75.
  • Luo C et al. (2013) MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Cancer Letters 341: 240-7.
  • Hassel JC et al. (2013) Lecithin/retinol acyltransferase as a potential prognostic marker for malignant melanoma. Exp Dermatol 22: 757-9.

2012

  • Savchenko MS et al. (2012) Autoantibodies against a Ca2+-binding protein recoverin in blood sera of patients with various oncological diseases. Oncology Letters 3: 377-82.
  • Grund SE et al. (2012) Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells. Neoplasia 14: 238-48.
  • Bai AH et al. (2012) MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol 123: 529-38.
  • Amann PM et al. (2012) Vitamin A metabolism in benign and malignant skin cells: Importance of lecithin/retinol acyltransferase and RPE65. J Cell Physiol 227: 718-28.
  • Amann PM et al. (2012) Expression and activity of alcohol and aldehyde dehydrogenases in melanoma cells and in melanocytes. J Cell Biochem 113: 792-9.
  • Abschuetz O*, Osen W* et al. (2012) T-cell mediated immune responses induced in ret transgenic mouse model of malignant melanoma. Cancers 4: 490-503.

to top